Evaluation Institute Signs Business Agreement with U.S. National Cancer Institute

News Healthcare & Pharma General Updates

Date: 21st Nov, 2024 Source: Korea Food and Drug Administration (KFDA) Country: South Korea Original Source

Brief

"On November 21, 2024, the Korea Food and Drug Administration (KFDA) issued an update regarding Evaluation Institute Signs Business Agreement with U.S. National Cancer Institute. The KFDA's Evaluation Institute and the US National Cancer Institute signed a Memorandum of Understanding (MOU) on November 19, 2024, to collaborate on research related to cancer diagnosis, treatment, and prevention."

This content is restricted.

Highlights content goes here...

This content is restricted.

Korea Food and Drug Administration (KFDA)

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

Evaluation Institute Signs Business Agreement with U.S. National Cancer Institute

Brief

Korea Food and Drug Administration (KFDA)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

Evaluation Institute Signs Business Agreement with U.S. National Cancer Institute

Brief

Korea Food and Drug Administration (KFDA)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.